Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The American Heart Hospital Journal|January 4, 2011
Patient demographics, complications, and hospital utilization in 250 consecutive device implants in a new community hospital electrophysiology program--implications for 'niche' hospitalsJeffrey L Williams, David Lugg, Robert Gray, et al.
Biological Psychiatry|March 21, 2002
The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophreniaDavid Cotter, Sabine Landau, Clare Beasley, et al.
Neuromodulation : Journal of the International Neuromodulation Society|August 12, 2020
Examining the Need to Standardize Implanted Stimulator Connectors: NANS Survey ResultsRichard B North, Peter E Konrad, Jack W Judy, et al.
Veterinary Sciences|October 25, 2017
Intranuclear Inclusions in Renal Tubular Epithelium in Immunodeficient Mice Stain with Antibodies for Bovine Papillomavirus Type 1 L1 ProteinElizabeth McInnes, Mark Bennett, Mandy O'Hara, et al.
Paediatric Anaesthesia|April 24, 2019
Changing healthcare provider and parent behaviors in the pediatric post-anesthesia-care-unit to reduce child pain: Nurse and parent training in postoperative stressBrooke N Jenkins, Michelle A Fortier, Robert Stevenson, et al.
BJUI Compass|October 21, 2022
Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancerNicholas D James, Ayesha Ali, Ann Pope, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 13, 2008
Vernakalant: pharmacology electrophysiology, safety and efficacyGerald V Naccarelli, Deborah L Wolbrette, Soraya Samii, et al.
Expert Opinion on Investigational Drugs|May 2, 2008
Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillationGerald V Naccarelli, Deborah L Wolbrette, Soraya Samii, et al.
British Journal of Cancer|January 8, 2024
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspectiveRobert J Jones, Simon J Crabb, Mark Linch, et al.
The Oncologist|October 30, 2025
UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinomaSyed Hussain, Aisling Carr, Simon John Crabb, et al.
Pageof 3